Varian, a Siemens Healthineers Company
Clinical trials sponsored by Varian, a Siemens Healthineers Company, explained in plain language.
A medical device company specializing in radiation therapy and oncology solutions.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New radiation technique aims to slash gut damage in bladder cancer patients Results expected Dec 2026 (estimated)
- New radiation technique aims to spare the urethra in prostate cancer treatment Results expected Jan 2027 (estimated)
- Can a new radiation machine cut breath holds for cancer patients? Results expected Feb 2027 (estimated)
- Can a flash of radiation ease bone pain in seconds? Results expected May 2027 (estimated)
-
New adaptive radiation aims to spare the gut in pancreatic cancer
Disease control Recruiting nowThis trial is testing a new type of radiation therapy that adapts daily to the exact shape and position of a pancreatic tumor. The goal is to deliver a high, tumor-killing dose while minimizing damage to nearby stomach and intestines. About 134 people with borderline resectable o…
Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New radiation technique aims to spare the urethra in prostate cancer treatment
Disease control Recruiting nowThis trial is testing a daily adaptive radiation therapy for low to intermediate risk prostate cancer that spares the urethra. The goal is to reduce urinary side effects compared to standard radiation. About 132 participants will receive this tailored radiation, and their urinary…
Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Zapping the heart: could one radiation dose replace repeat surgery for lethal rhythms?
Disease control Recruiting nowThis study tests a new approach for people with a life-threatening fast heart rhythm called ventricular tachycardia (VT) that keeps coming back after standard treatment. It compares a single, targeted radiation dose (cardiac radioablation) to a repeat catheter ablation, which is …
Sponsor: Varian, a Siemens Healthineers Company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New radiation technique aims to spare cervical cancer patients from gut woes
Symptom relief Recruiting nowThis trial tests a new type of radiation therapy for cervical cancer that adjusts the beam daily based on the patient's anatomy. The goal is to reduce acute bowel side effects like diarrhea and urgency. About 125 patients with advanced cervical cancer will receive this treatment,…
Sponsor: Varian, a Siemens Healthineers Company • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a new radiation machine cut breath holds for cancer patients?
Knowledge-focused Recruiting nowResearchers are studying whether a next-generation radiation delivery system can run a complete treatment workflow while patients hold their breath. The trial enrolls about 20 adults with tumors in the chest or upper abdomen who are already scheduled for stereotactic body radiati…
Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New scanner could sharpen cancer radiation treatment
Knowledge-focused Recruiting nowThis study tests a new type of CT scanner called HyperSight, designed to produce clearer images during radiation therapy for cancer. About 50 adults with various cancers will receive their daily radiation using both the new and standard imaging. Researchers will compare image qua…
Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC